Literature DB >> 16415345

Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase.

Mitsuru Machide1, Atsuko Hashigasako, Kunio Matsumoto, Toshikazu Nakamura.   

Abstract

Contact inhibition, the inhibition of cell proliferation by tight cell-cell contact is a fundamental characteristic of normal cells. Using primary cultured hepatocytes, we investigated the mechanisms of contact inhibition that decrease the mitogenic activity of hepatocyte growth factor (HGF), focusing on the regulation of c-Met/HGF-receptor activation. In hepatocytes cultured at a sparse cell density, HGF stimulation induced prolonged c-Met tyrosine phosphorylation for over 5 h and a marked mitogenic response. In contrast, HGF stimulation induced transient c-Met tyrosine phosphorylation in <3 h and failed to induce mitogenic response in hepatocytes cultured at a confluent cell density. Treatment of the confluent cells with HGF plus orthovanadate, a broad spectrum protein-tyrosine phosphatase inhibitor, however, prolonged c-Met tyrosine phosphorylation for over 5 h and permitted the subsequent mitogenic response. The mitogenic response to HGF was associated with the duration of c-Met tyrosine phosphorylation even in the sparse cells. We found that the activity and expression of the protein-tyrosine phosphatase LAR increased following HGF stimulation specifically in confluent hepatocytes and not in sparse hepatocytes. LAR and c-Met were associated, and purified LAR dephosphorylated tyrosine-phosphorylated c-Met in in vitro phosphatase reactions. Furthermore, antisense oligonucleotides specific for LAR mRNA suppressed the expression of LAR, allowed prolonged c-Met tyrosine phosphorylation, and led to acquisition of a mitogenic response in hepatocytes even under the confluent condition. Thus functional association of LAR and c-Met underlies the inhibition of c-Met-mediated mitogenic signaling through the dephosphorylation of c-Met, which specifically occurs under the confluent condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415345     DOI: 10.1074/jbc.M512298200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  An overview of the c-MET signaling pathway.

Authors:  Shawna Leslie Organ; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

2.  Homozygous truncating PTPRF mutation causes athelia.

Authors:  Guntram Borck; Liat de Vries; Hsin-Jung Wu; Pola Smirin-Yosef; Gudrun Nürnberg; Irina Lagovsky; Luis Henrique Ishida; Patrick Thierry; Dagmar Wieczorek; Peter Nürnberg; John Foley; Christian Kubisch; Lina Basel-Vanagaite
Journal:  Hum Genet       Date:  2014-04-30       Impact factor: 4.132

3.  Protein-tyrosine phosphatase 1B modulates early endosome fusion and trafficking of Met and epidermal growth factor receptors.

Authors:  Veena Sangwan; Jasmine Abella; Andrea Lai; Nicholas Bertos; Matthew Stuible; Michel L Tremblay; Morag Park
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

4.  Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function.

Authors:  Yiru Xu; Wei Xia; Dustin Baker; Jin Zhou; Hyuk Chol Cha; John J Voorhees; Gary J Fisher
Journal:  J Biol Chem       Date:  2011-03-15       Impact factor: 5.157

Review 5.  MET signalling: principles and functions in development, organ regeneration and cancer.

Authors:  Livio Trusolino; Andrea Bertotti; Paolo M Comoglio
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

6.  Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.

Authors:  Veena Sangwan; Grigorios N Paliouras; Jasmine V Abella; Nadia Dubé; Anie Monast; Michel L Tremblay; Morag Park
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

7.  Unbiased identification of substrates of protein tyrosine phosphatase ptp-3 in C. elegans.

Authors:  Christopher J Mitchell; Min-Sik Kim; Jun Zhong; Raja Sekhar Nirujogi; Anjun K Bose; Akhilesh Pandey
Journal:  Mol Oncol       Date:  2016-03-25       Impact factor: 6.603

8.  Association of protein tyrosine phosphatases (PTPs)-1B with c-Met receptor and modulation of corneal epithelial wound healing.

Authors:  Azucena Kakazu; Guru Sharma; Haydee E P Bazan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07       Impact factor: 4.799

9.  Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats.

Authors:  Yuji Nishikawa; Naoto Ohi; Akiko Yagisawa; Yuko Doi; Yohei Yamamoto; Masayuki Yoshida; Takuo Tokairin; Toshiaki Yoshioka; Yasufumi Omori; Katsuhiko Enomoto
Journal:  Am J Pathol       Date:  2009-01-22       Impact factor: 4.307

10.  Regulation of Platelet Derived Growth Factor Signaling by Leukocyte Common Antigen-related (LAR) Protein Tyrosine Phosphatase: A Quantitative Phosphoproteomics Study.

Authors:  Adil R Sarhan; Trushar R Patel; Andrew J Creese; Michael G Tomlinson; Carina Hellberg; John K Heath; Neil A Hotchin; Debbie L Cunningham
Journal:  Mol Cell Proteomics       Date:  2016-04-13       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.